Contact this trialFirst, we need to learn more about you.
Cell Therapy
Autologous Cell Therapy for Critical Limb Ischemia
Recruiting0 awardsPhase 1 & 2
New Haven, Connecticut
This trial will test the feasibility of using a mix of cells enriched for endothelial progenitor cells and multipotent adult hematopoietic stem/progenitor cells to treat peripheral arterial disease and critical limb ischemia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service